Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001741533-25-000003

CHIEF MEDICAL OFFICER sold 82,542 shares at $37.14 ($3,065,610)

  • CHIEF MEDICAL OFFICER acquired 82,542 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Paolini John F. · CHIEF MEDICAL OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-31 Exercise or conversion : show line 1 in the form 10b5-1 +36,542 $3.80 $138,860 97,866 D
2025-10-31 Exercise or conversion : show line 2 in the form 10b5-1 +46,000 $8.83 $406,180 143,866 D
2025-10-31 Sale : show line 3 in the form 10b5-1 −82,542 $37.14 $3,065,610 61,324 D
Open-market sales · 82,542 sh · avg $37.14 · $3,065,610

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-10-31 Exercise or conversion : show line 4 in the form 10b5-1 Share Option −36,542 0 D
2025-10-31 Exercise or conversion : show line 5 in the form 10b5-1 Share Option −46,000 0 D
Loading xslF345X05/form4-11042025_091113.xml…